The synthesis of neurotensin antagonist SR 48692 for prostate cancer research. (2013)
Attributed to:
A Synthesis Programme at Cambridge
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bmc.2013.04.075
PubMed Identifier: 23721919
Publication URI: http://europepmc.org/abstract/MED/23721919
Type: Journal Article/Review
Volume: 21
Parent Publication: Bioorganic & medicinal chemistry
Issue: 14
ISSN: 0968-0896